Stocks · News reference
Trinity Biotech Announces ADS Ratio Change From One ADS Representing 20 Ordinary Shares To One ADS Representing 600 Ordinary Shares
For Trinity Biotech Plc ADS holders, the change in the ADS ratio will have the same effect as a one for-thirty reverse ADS split and is intended to i) enable the Company to regain compliance with the $1.00 Nasdaq
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 22, 2026, 11:19 AM
- Checked
- Jul 22, 2026, 11:19 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Trinity Biotech Receives ~$7M Of Additional Investment From Funds Managed By Perceptive Advisors; Regains Compliance With Nasdaq Minimum Bid Price Requirement
The Company also announced that it has regained compliance with Nasdaq’s minimum bid price requirement, marking another positive development as Trinity Biotech continues to execute its strategic priorities.Perceptive
Read original at benzingaTrading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Read original at benzingaTrinity Biotech shares are trading lower after the company announced a ADS ratio change that has the same effect of a 1-for-30 reverse ADS split.
Read original at benzinga